(Q50789212)

19 March 2018

title

Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation. (English)

1 reference

19 March 2018

author

Jonas Mattsson

6

1 reference

19 March 2018

author name string

Anna Nordlander

1

1 reference

19 March 2018

Michael Uhlin

2

1 reference

19 March 2018

Olle Ringdén

3

1 reference

19 March 2018

Gunilla Kumlien

4

1 reference

19 March 2018

Dan Hauzenberger

5

1 reference

19 March 2018

publication date

21 June 2011

1 reference

19 March 2018

published in

Transplant Immunology

1 reference

19 March 2018

volume

25

1 reference

19 March 2018

issue

2-3

1 reference

19 March 2018

page(s)

153-158

1 reference

19 March 2018

The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Graft failure after allogeneic hematopoietic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Identification of the hemangioblast in postnatal life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

The pathophysiology of acute graft-versus-host disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease: implications for its use?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Clinical use of umbilical cord blood hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

The impact of anti-HLA antibodies on unrelated cord blood transplantations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

Improved graft survival in ABO-incompatible living donor kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

ABO-incompatible kidney transplantation using both A2 and non-A2 living donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

The impact of HLA antibodies on engraftment of unrelated cord blood transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.06.001

10.1016/J.TRIM.2011.06.001

7 January 2021

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018